• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰腺癌中异常信号通路:双室观点。

Aberrant signaling pathways in pancreatic cancer: a two compartment view.

机构信息

Schulze Center for Novel Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA.

出版信息

Mol Carcinog. 2012 Jan;51(1):25-39. doi: 10.1002/mc.20827.

DOI:10.1002/mc.20827
PMID:22162229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3253704/
Abstract

Pancreatic cancer is a devastating disease with historically limited success in treatment and a poor prognosis. Pancreatic cancer appears to have a progressive pathway of development, initiating from well-described pancreatic intraepithelial neoplasia lesions and concluding with invasive carcinoma. These early lesions have been shown to harbor-specific alterations in signaling pathways that remain throughout this tumorigenesis process. Meanwhile, new alterations occur during this process of disease progression to have a cumulative effect. This series of events not only impacts the epithelial cells comprising the tumor, but they may also affect the surrounding stromal cells. The result is the formation of complex signaling networks of communication between the tumor epithelial cell and the stromal cell compartments to promote a permissive and cooperative environment. This article highlights some of the most common pathway aberrations involved with this disease, and how these may subsequently affect one or both cellular compartments. Consequently, furthering our understanding of these pathways in terms of their function on the tumoral epithelial and stromal compartments may prove to be crucial to the development of targeted and more successful therapies in the future.

摘要

胰腺癌是一种具有破坏性的疾病,在治疗方面历史上收效甚微,预后不良。胰腺癌似乎具有一个渐进的发展途径,从描述明确的胰腺上皮内瘤变病变开始,并以浸润性癌结束。这些早期病变表现出在信号通路中存在特定的改变,这些改变在整个肿瘤发生过程中仍然存在。同时,在疾病进展过程中会发生新的改变,从而产生累积效应。这一系列事件不仅影响构成肿瘤的上皮细胞,还可能影响周围的基质细胞。结果是肿瘤上皮细胞和基质细胞之间形成了复杂的信号网络交流,以促进一个许可和合作的环境。本文重点介绍了一些与这种疾病相关的最常见的途径异常,以及这些途径如何随后影响一个或两个细胞区室。因此,进一步了解这些途径在肿瘤上皮和基质区室中的功能可能对未来开发靶向和更成功的治疗方法至关重要。

相似文献

1
Aberrant signaling pathways in pancreatic cancer: a two compartment view.胰腺癌中异常信号通路:双室观点。
Mol Carcinog. 2012 Jan;51(1):25-39. doi: 10.1002/mc.20827.
2
Genetic alterations associated with progression from pancreatic intraepithelial neoplasia to invasive pancreatic tumor.与从胰腺上皮内瘤变进展为侵袭性胰腺肿瘤相关的遗传改变。
Gastroenterology. 2013 Nov;145(5):1098-1109.e1. doi: 10.1053/j.gastro.2013.07.049. Epub 2013 Aug 2.
3
Stromal response to Hedgehog signaling restrains pancreatic cancer progression.基质对刺猬信号通路的反应抑制胰腺癌进展。
Proc Natl Acad Sci U S A. 2014 Jul 29;111(30):E3091-100. doi: 10.1073/pnas.1411679111. Epub 2014 Jul 14.
4
Hedgehog/Ras interactions regulate early stages of pancreatic cancer.刺猬信号通路/鼠肉瘤病毒癌基因同源物相互作用调节胰腺癌的早期阶段。
Genes Dev. 2006 Nov 15;20(22):3161-73. doi: 10.1101/gad.1470806.
5
Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo.胰腺中p16的破坏和Kras的激活会增加体内导管腺癌的形成和转移。
Oncotarget. 2011 Nov;2(11):862-73. doi: 10.18632/oncotarget.357.
6
New biomarkers and targets in pancreatic cancer and their application to treatment.胰腺癌的新型生物标志物和靶点及其在治疗中的应用。
Nat Rev Gastroenterol Hepatol. 2012 Aug;9(8):435-44. doi: 10.1038/nrgastro.2012.119. Epub 2012 Jun 26.
7
Embelin suppresses growth of human pancreatic cancer xenografts, and pancreatic cancer cells isolated from KrasG12D mice by inhibiting Akt and Sonic hedgehog pathways.鞣花酸通过抑制 Akt 和 Sonic hedgehog 通路抑制人胰腺癌细胞异种移植瘤的生长,以及从 KrasG12D 小鼠中分离出的胰腺癌细胞。
PLoS One. 2014 Apr 2;9(4):e92161. doi: 10.1371/journal.pone.0092161. eCollection 2014.
8
Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia.Notch和Kras将胰腺腺泡细胞重编程为导管上皮内瘤变。
Proc Natl Acad Sci U S A. 2008 Dec 2;105(48):18907-12. doi: 10.1073/pnas.0810111105. Epub 2008 Nov 21.
9
KRAS in pancreatic cancer.胰腺癌中的KRAS
JOP. 2014 Jul 28;15(4):303-5. doi: 10.6092/1590-8577/2660.
10
KRAS2 mutations in human pancreatic acinar-ductal metaplastic lesions are limited to those with PanIN: implications for the human pancreatic cancer cell of origin.人胰腺腺泡-导管化生病变中的KRAS2突变仅限于伴有胰腺上皮内瘤变(PanIN)的病变:对人胰腺癌起源细胞的启示。
Mol Cancer Res. 2009 Feb;7(2):230-6. doi: 10.1158/1541-7786.MCR-08-0206. Epub 2009 Feb 10.

引用本文的文献

1
Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications.沉默调节蛋白作为胰腺癌的关键调节因子:对信号传导机制及治疗意义的见解
Cancers (Basel). 2024 Dec 6;16(23):4095. doi: 10.3390/cancers16234095.
2
PSF toolkit: an R package for pathway curation and topology-aware analysis.PSF工具包:一个用于通路整理和拓扑感知分析的R软件包。
Front Genet. 2023 Aug 23;14:1264656. doi: 10.3389/fgene.2023.1264656. eCollection 2023.
3
Targeting miRNA and using miRNA as potential therapeutic options to bypass resistance in pancreatic ductal adenocarcinoma.针对 miRNA 并将其用作潜在的治疗选择,以绕过胰腺导管腺癌的耐药性。
Cancer Metastasis Rev. 2023 Sep;42(3):725-740. doi: 10.1007/s10555-023-10127-w. Epub 2023 Jul 25.
4
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study.胰腺导管腺癌的靶向治疗:机制与临床研究。
MedComm (2020). 2023 Feb 19;4(2):e216. doi: 10.1002/mco2.216. eCollection 2023 Apr.
5
Deeper insights into long-term survival heterogeneity of pancreatic ductal adenocarcinoma (PDAC) patients using integrative individual- and group-level transcriptome network analyses.利用整合的个体和群组转录组网络分析深入了解胰腺导管腺癌 (PDAC) 患者的长期生存异质性。
Sci Rep. 2022 Jun 30;12(1):11027. doi: 10.1038/s41598-022-14592-1.
6
Proteogenomic analysis of pancreatic cancer subtypes.胰腺癌亚型的蛋白质基因组分析。
PLoS One. 2021 Sep 10;16(9):e0257084. doi: 10.1371/journal.pone.0257084. eCollection 2021.
7
Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy.胰腺导管腺癌中的非编码RNA:改善诊断和治疗的新方法
Transl Oncol. 2021 Jul;14(7):101090. doi: 10.1016/j.tranon.2021.101090. Epub 2021 Apr 5.
8
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer.胰腺癌遗传易感性的多层次 GWAS 后评估。
Genome Med. 2021 Feb 1;13(1):15. doi: 10.1186/s13073-020-00816-4.
9
Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma.在早期可切除的胰腺导管腺癌中,桥粒珠蛋白表达增加与丝裂原活化蛋白激酶(MAPK)和磷脂酰肌醇-3激酶/蛋白激酶B(PI3K/AKT)信号通路的上调有关。
Oncol Lett. 2020 Jun;19(6):4133-4141. doi: 10.3892/ol.2020.11473. Epub 2020 Mar 23.
10
Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance.胰腺星状细胞释放脱氧胞苷促进吉西他滨耐药。
Cancer Res. 2019 Nov 15;79(22):5723-5733. doi: 10.1158/0008-5472.CAN-19-0960. Epub 2019 Sep 4.

本文引用的文献

1
Role of pancreatic stellate cells in pancreatic cancer metastasis.胰腺星状细胞在胰腺癌转移中的作用。
Am J Pathol. 2010 Nov;177(5):2585-96. doi: 10.2353/ajpath.2010.090899. Epub 2010 Oct 7.
2
Isolation of quiescent human pancreatic stellate cells: a promising in vitro tool for studies of human pancreatic stellate cell biology.人静止胰腺星状细胞的分离:研究人胰腺星状细胞生物学的有前途的体外工具。
Pancreatology. 2010;10(4):434-43. doi: 10.1159/000260900. Epub 2010 Aug 20.
3
Notch2 is required for progression of pancreatic intraepithelial neoplasia and development of pancreatic ductal adenocarcinoma.Notch2 对于胰腺上皮内瘤变的进展和胰腺导管腺癌的发生是必需的。
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13438-43. doi: 10.1073/pnas.1002423107. Epub 2010 Jul 12.
4
Sequential activation of NFAT and c-Myc transcription factors mediates the TGF-beta switch from a suppressor to a promoter of cancer cell proliferation.NFAT 和 c-Myc 转录因子的级联激活介导了 TGF-β从肿瘤细胞增殖的抑制剂向促进剂的转换。
J Biol Chem. 2010 Aug 27;285(35):27241-27250. doi: 10.1074/jbc.M110.100438. Epub 2010 Jun 1.
5
THE CLINICAL ASPECTS OF THE HISTOLOGY AND PATHOLOGY OF THE PANCREAS.胰腺组织学与病理学的临床方面
Can Med Assoc J. 1934 Feb;30(2):148-52.
6
Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts.Smoothened 的过表达激活了胰腺癌相关成纤维细胞中的 sonic hedgehog 信号通路。
Clin Cancer Res. 2010 Mar 15;16(6):1781-9. doi: 10.1158/1078-0432.CCR-09-1913. Epub 2010 Mar 9.
7
Beta-catenin blocks Kras-dependent reprogramming of acini into pancreatic cancer precursor lesions in mice.β-连环蛋白阻断 Kras 依赖性的小鼠腺泡重编程为胰腺癌前病变。
J Clin Invest. 2010 Feb;120(2):508-20. doi: 10.1172/JCI40045. Epub 2010 Jan 11.
8
Tgfbr1 haploinsufficiency inhibits the development of murine mutant Kras-induced pancreatic precancer.Tgfbr1 杂合不足抑制了小鼠突变 Kras 诱导的胰腺前癌的发展。
Cancer Res. 2009 Dec 15;69(24):9169-74. doi: 10.1158/0008-5472.CAN-09-1705.
9
NFAT-induced histone acetylation relay switch promotes c-Myc-dependent growth in pancreatic cancer cells.NFAT 诱导的组蛋白乙酰化接力开关促进胰腺癌细胞中 c-Myc 依赖性生长。
Gastroenterology. 2010 Mar;138(3):1189-99.e1-2. doi: 10.1053/j.gastro.2009.10.045. Epub 2009 Nov 6.
10
Roles of pancreatic stellate cells in pancreatic inflammation and fibrosis.胰腺星状细胞在胰腺炎症和纤维化中的作用。
Clin Gastroenterol Hepatol. 2009 Nov;7(11 Suppl):S48-54. doi: 10.1016/j.cgh.2009.07.038.